8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Feb 17, 2026·SEC
Material company update
Feb 4, 2026·SEC
Natural Health Trends Corp.(NHTC)Earnings, Financials & Key Ratios
NHTC•NASDAQ
$3.10
$35M mkt cap·Price updated May 6, 2026
AboutNatural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, including liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprising herbal supplements. It also provides beauty products, such as age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products, which include weight management and energy enhancing supplements. In addition, the company offers home appliances; daily products, such as oral care, hair care, and body care; and home appliances products. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, Cayman Islands, Mexico, Peru, Hong Kong, Taiwan, China, Singapore, Malaysia, Thailand, Vietnam, South Korea, Japan, India, Russia, Kazakhstan, and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Tsim Sha Tsui, Hong Kong.Show more
- Revenue$40M-7.4%
- EBITDA-$2M-45.5%
- Net Income-$882K-254.2%
- EPS (Diluted)-0.08-254.0%
- Gross Margin73.54%-0.6%
- EBITDA Margin-4.27%-57.1%
- Operating Margin-4.55%-50.3%
- Net Margin-2.22%-266.5%
- ROE-3.13%-304.0%
- ROIC-6.5%+63.8%
- Debt/Equity0.13+66.3%
NHTC Key Insights
Natural Health Trends Corp. (NHTC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Efficient asset utilization: 1.0x turnover
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Sales declining 8.5% over 5 years
- ✗Thin 5Y average net margin of 0.6%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NHTC Price & Volume
Natural Health Trends Corp. (NHTC) stock price & volume — 10-year historical chart
Loading chart...
NHTC Growth Metrics
Natural Health Trends Corp. (NHTC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-17.27%
5 Years-8.52%
3 Years-6.8%
TTM-10.54%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-328.85%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-332.95%
Return on Capital
10 Years13.73%
5 Years-2.12%
3 Years-4.07%
Last Year-6.1%
NHTC Peer Comparison
Natural Health Trends Corp. (NHTC) competitors in Beauty and Personal Care Retail — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 QNST | 742.06M | 13.02 | 161.34 | 78.27% | 5.64% | 24.45% | 0.04 | |
 AVAV | 8.71B | 174.37 | 112.50 | 14.5% | -13.93% | -6.41% | 0.07 | |
 NUS | 353.79M | 7.34 | 2.31 | -14.26% | 7.02% | 13.7% | 0.35 | |
 USNA | 369.32M | 20.01 | 34.50 | 8.28% | 1.16% | 1.84% | 0.02 | |
 NATR | 459.31M | 26.24 | 24.75 | 5.67% | 4.07% | 11.85% | 0.12 | |
 HLF | 1.7B | 16.44 | 7.47 | 0.89% | 4.67% | |||
 PLBY | 189.54M | 1.68 | -12.92 | 4.13% | -10.48% | -247.79% | 1.30 | |
 MGPI | 412.89M | 19.32 | -3.87 | -23.77% | -45.97% | -32.05% | 0.37 |
Compare NHTC vs Peers
Natural Health Trends Corp. (NHTC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NHTC Income Statement
Natural Health Trends Corp. (NHTC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 197.56M | 191.91M | 77.61M | 62.07M | 60.01M | 49.13M | 43.92M | 42.96M | 39.78M | 38.24M |
| Revenue Growth % | -31.34% | -2.86% | -59.56% | -20.03% | -3.33% | -18.12% | -10.6% | -2.19% | -7.42% | -10.54% |
| Cost of Goods Sold | 38.65M | 39.37M | 20.1M | 16.99M | 15.01M | 12.66M | 11.18M | 11.18M | 10.52M | 10.01M |
| COGS % of Revenue | 19.56% | 20.51% | 25.9% | 27.37% | 25.01% | 25.77% | 25.44% | 26.02% | 26.46% | - |
| Gross Profit | 158.92M▲ 0% | 152.54M▼ 4.0% | 57.51M▼ 62.3% | 45.08M▼ 21.6% | 44.99M▼ 0.2% | 36.47M▼ 18.9% | 32.75M▼ 10.2% | 31.79M▼ 2.9% | 29.25M▼ 8.0% | 28.24M▲ 0% |
| Gross Margin % | 80.44% | 79.49% | 74.1% | 72.63% | 74.99% | 74.23% | 74.56% | 73.98% | 73.54% | 73.84% |
| Gross Profit Growth % | -31.74% | -4.01% | -62.3% | -21.61% | -0.19% | -18.94% | -10.21% | -2.94% | -7.97% | - |
| Operating Expenses | 115.86M | 118.81M | 64.53M | 44.41M | 43.42M | 36.74M | 34.42M | 33.08M | 31.06M | 30.15M |
| OpEx % of Revenue | 58.64% | 61.91% | 83.15% | 71.55% | 72.37% | 74.78% | 78.36% | 77.01% | 78.09% | - |
| Selling, General & Admin | 115.86M | 118.81M | 62.77M | 44.41M | 43.42M | 36.74M | 34.42M | 33.08M | 31.06M | 30.15M |
| SG&A % of Revenue | 58.64% | 61.91% | 80.87% | 71.55% | 72.37% | 74.78% | 78.36% | 77.01% | 78.09% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 367K | 789K | 1.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 43.06M▲ 0% | 33.73M▼ 21.7% | -7.02M▼ 120.8% | 669K▲ 109.5% | 1.57M▲ 134.8% | -270K▼ 117.2% | -1.67M▼ 518.9% | -1.3M▲ 22.3% | -1.81M▼ 39.2% | -1.94M▲ 0% |
| Operating Margin % | 21.8% | 17.58% | -9.05% | 1.08% | 2.62% | -0.55% | -3.8% | -3.02% | -4.55% | -5.06% |
| Operating Income Growth % | -32.86% | -21.66% | -120.82% | 109.53% | 134.83% | -117.19% | -518.89% | 22.26% | -39.18% | - |
| EBITDA | 43.59M | 34.16M | -6.64M | 1.08M | 1.87M | -66K | -1.51M | -1.17M | -1.7M | -1.65M |
| EBITDA Margin % | 22.07% | 17.8% | -8.55% | 1.74% | 3.12% | -0.13% | -3.43% | -2.72% | -4.27% | -4.31% |
| EBITDA Growth % | -32.44% | -21.65% | -119.43% | 116.26% | 73.31% | -103.53% | -2183.33% | 22.5% | -45.46% | -42.84% |
| D&A (Non-Cash Add-back) | 536K | 424K | 387K | 410K | 299K | 204K | 164K | 131K | 109K | 68K |
| EBIT | 43.43M | 34.52M | -5.26M | 669K | 1.57M | -270K | -1.67M | -1.3M | -567K | -1.51M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 367K | 789K | 1.43M | 821K | -61K | 872K | 2.42M | 1.92M | 1.24M | 1.07M |
| Pretax Income | 43.43M▲ 0% | 34.52M▼ 20.5% | -5.6M▼ 116.2% | 1.49M▲ 126.6% | 1.51M▲ 1.3% | 602K▼ 60.1% | 745K▲ 23.8% | 620K▼ 16.8% | -567K▼ 191.5% | -866K▲ 0% |
| Pretax Margin % | 21.98% | 17.99% | -7.21% | 2.4% | 2.52% | 1.23% | 1.7% | 1.44% | -1.43% | -2.26% |
| Income Tax | 19.85M | 3.49M | 14K | 647K | 425K | 289K | 177K | 48K | 315K | 292K |
| Effective Tax Rate % | 45.71% | 10.1% | -0.25% | 43.42% | 28.15% | 48.01% | 23.76% | 7.74% | -55.56% | -33.72% |
| Net Income | 23.58M▲ 0% | 31.04M▲ 31.6% | -5.61M▼ 118.1% | 843K▲ 115.0% | 1.08M▲ 28.7% | 313K▼ 71.2% | 568K▲ 81.5% | 572K▲ 0.7% | -882K▼ 254.2% | -1.16M▲ 0% |
| Net Margin % | 11.93% | 16.17% | -7.23% | 1.36% | 1.81% | 0.64% | 1.29% | 1.33% | -2.22% | -3.03% |
| Net Income Growth % | -57.2% | 31.63% | -118.08% | 115.02% | 28.71% | -71.15% | 81.47% | 0.7% | -254.2% | -328.85% |
| Net Income (Continuing) | 23.58M | 31.04M | -5.61M | 843K | 1.08M | 313K | 568K | 572K | -882K | -1.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 2.09▲ 0% | 2.74▲ 31.1% | -0.52▼ 119.0% | 0.07▲ 114.2% | 0.10▲ 28.7% | 0.03▼ 71.2% | 0.05▲ 81.0% | 0.05▲ 0.4% | -0.08▼ 254.0% | -0.11▲ 0% |
| EPS Growth % | -56.73% | 31.1% | -118.98% | 114.19% | 28.73% | -71.16% | 81.02% | 0.4% | -254.02% | -332.95% |
| EPS (Basic) | 2.10 | 2.75 | -0.52 | 0.08 | 0.10 | 0.03 | 0.05 | 0.05 | -0.08 | - |
| Diluted Shares Outstanding | 11.27M | 11.32M | 10.87M | 11.42M | 11.42M | 11.42M | 11.46M | 11.49M | 11.5M | 10.14M |
| Basic Shares Outstanding | 11.25M | 11.3M | 10.87M | 10.63M | 11.02M | 11.36M | 11.44M | 11.47M | 11.5M | 10.14M |
| Dividend Payout Ratio | 73.03% | 101.54% | - | 1083.99% | 842.21% | 2919.49% | 1622.36% | 1610.66% | - | - |
NHTC Balance Sheet
Natural Health Trends Corp. (NHTC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 151.24M | 150.19M | 108.38M | 99.74M | 93.47M | 77.55M | 64.23M | 50.98M | 34.19M | 26.54M |
| Cash & Short-Term Investments | 135.31M | 132.65M | 96.03M | 92.37M | 83.84M | 69.67M | 56.18M | 43.94M | 28.87M | 21.23M |
| Cash Only | 135.31M | 132.65M | 96.03M | 92.37M | 83.84M | 69.67M | 56.18M | 13.53M | 6.81M | 9.22M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.41M | 22.06M | 12.01M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - |
| Inventory | 8.4M | 12.16M | 6.4M | 3.78M | 5.26M | 4.53M | 4.29M | 3.27M | 2.05M | 1.97M |
| Days Inventory Outstanding | 79.32 | 112.79 | 116.27 | 81.19 | 127.84 | 130.45 | 140.22 | 106.84 | 71 | 81.55 |
| Other Current Assets | 7.53M | 5.37M | 5.94M | 3.6M | 4.37M | 3.36M | 3.76M | 3.77M | 3.27M | 3.33M |
| Total Non-Current Assets | 8.31M | 7.73M | 10.12M | 6.2M | 4.89M | 5.27M | 4.86M | 4.38M | 4.23M | 5.41M |
| Property, Plant & Equipment | 1.15M | 934K | 3.87M | 4.28M | 3.48M | 4.39M | 3.58M | 2.69M | 2.02M | 3.15M |
| Fixed Asset Turnover | 171.94x | 205.47x | 20.06x | 14.49x | 17.22x | 11.20x | 12.25x | 15.98x | 19.67x | 15.88x |
| Goodwill | 1.76M | 1.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 3.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 42K |
| Other Non-Current Assets | 796K | 3.83M | 4.21M | 1.19M | 1.09M | 685K | 908K | 1.31M | 1.92M | 7.43M |
| Total Assets | 159.55M▲ 0% | 157.92M▼ 1.0% | 118.5M▼ 25.0% | 105.94M▼ 10.6% | 98.36M▼ 7.2% | 82.82M▼ 15.8% | 69.09M▼ 16.6% | 55.36M▼ 19.9% | 38.43M▼ 30.6% | 31.95M▲ 0% |
| Asset Turnover | 1.24x | 1.22x | 0.65x | 0.59x | 0.61x | 0.59x | 0.64x | 0.78x | 1.04x | 0.97x |
| Asset Growth % | 7.77% | -1.02% | -24.96% | -10.6% | -7.16% | -15.8% | -16.57% | -19.88% | -30.58% | -124.58% |
| Total Current Liabilities | 41.92M | 43.08M | 26.3M | 21.51M | 24.66M | 20.44M | 19.98M | 20.8M | 13.69M | 13.24M |
| Accounts Payable | 1.75M | 1.63M | 680K | 580K | 761K | 810K | 990K | 895K | 555K | 1.31M |
| Days Payables Outstanding | 16.54 | 15.12 | 12.35 | 12.46 | 18.51 | 23.35 | 32.34 | 29.22 | 19.25 | 34.97 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 869K | 958K |
| Deferred Revenue (Current) | 4.46M | 6.79M | 4.51M | 3.09M | 8.54M | 5.6M | 6.17M | 6.43M | 5.57M | 22.66M |
| Other Current Liabilities | 18.67M | 18.11M | 15.6M | 11.11M | 8.33M | 6.61M | 5.48M | 4.74M | 4.73M | 3.77M |
| Current Ratio | 3.61x | 3.49x | 4.12x | 4.64x | 3.79x | 3.79x | 3.21x | 2.45x | 2.50x | 2.50x |
| Quick Ratio | 3.41x | 3.20x | 3.88x | 4.46x | 3.58x | 3.57x | 3.00x | 2.29x | 2.35x | 2.35x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | 46.58 |
| Total Non-Current Liabilities | 27.01M | 24.98M | 17.13M | 16.74M | 14.21M | 12.23M | 7.51M | 1.69M | 1.31M | 2.24M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.13M | 0 |
| Capital Lease Obligations | 0 | 0 | 1.56M | 2.77M | 1.93M | 2.99M | 2.32M | 1.51M | 1.13M | 5.56M |
| Deferred Tax Liabilities | 56K | 186K | 202K | 216K | 153K | 141K | 135K | 174K | 180K | 704K |
| Other Non-Current Liabilities | 26.96M | 24.79M | 15.37M | 13.75M | 12.13M | 9.1M | 5.05M | 0 | -1.13M | -2.31M |
| Total Liabilities | 68.93M | 68.06M | 43.43M | 38.24M | 38.87M | 32.67M | 27.49M | 22.49M | 15M | 15.49M |
| Total Debt | 0 | 0 | 3.22M | 3.94M | 3.17M | 4.12M | 3.46M | 2.64M | 3.13M | 3.02M |
| Net Debt | -135.31M | -132.65M | -92.82M | -88.43M | -80.68M | -65.54M | -52.71M | -10.89M | -3.68M | -6.2M |
| Debt / Equity | - | - | 0.04x | 0.06x | 0.05x | 0.08x | 0.08x | 0.08x | 0.13x | 0.13x |
| Debt / EBITDA | - | - | - | 3.65x | 1.69x | - | - | - | - | -1.83x |
| Net Debt / EBITDA | -3.10x | -3.88x | - | -81.95x | -43.14x | - | - | - | - | 3.76x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 90.62M▲ 0% | 89.86M▼ 0.8% | 75.06M▼ 16.5% | 67.7M▼ 9.8% | 59.49M▼ 12.1% | 50.15M▼ 15.7% | 41.6M▼ 17.1% | 32.87M▼ 21.0% | 23.43M▼ 28.7% | 16.46M▲ 0% |
| Equity Growth % | 9.92% | -0.84% | -16.47% | -9.81% | -12.13% | -15.7% | -17.05% | -20.98% | -28.73% | -123.89% |
| Book Value per Share | 8.04 | 7.94 | 6.90 | 5.93 | 5.21 | 4.39 | 3.63 | 2.86 | 2.04 | 1.62 |
| Total Shareholders' Equity | 90.62M | 89.86M | 75.06M | 67.7M | 59.49M | 50.15M | 41.6M | 32.87M | 23.43M | 16.46M |
| Common Stock | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K |
| Retained Earnings | 44.91M | 44.43M | 16.12M | 7.82M | -231K | -9.06M | -17.7M | -26.34M | -36.44M | -37.45M |
| Treasury Stock | -40.57M | -39.75M | -25.9M | -25.9M | -25.9M | -25.9M | -24.34M | -24.4M | -24.4M | -30.36M |
| Accumulated OCI | -413K | -1.25M | -1.26M | -336K | -492K | -1M | -1.07M | -1.3M | -784K | -775K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NHTC Cash Flow Statement
Natural Health Trends Corp. (NHTC) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 26.61M | 29.71M | -18.64M | 1.89M | 1.02M | -4.85M | -4.28M | -3.37M | -6M | -6M |
| Operating CF Margin % | 13.47% | 15.48% | -24.01% | 3.04% | 1.69% | -9.88% | -9.74% | -7.84% | -15.08% | - |
| Operating CF Growth % | -49.97% | 11.67% | -162.73% | 110.11% | -46.1% | -577.56% | 11.83% | 21.3% | -78.11% | -88.73% |
| Net Income | 23.58M | 31.04M | -5.61M | 843K | 1.08M | 313K | 568K | 572K | -882K | -1.16M |
| Depreciation & Amortization | 536K | 424K | 387K | 410K | 299K | 204K | 164K | 131K | 109K | 68K |
| Stock-Based Compensation | 35K | 0 | 0 | 0 | 773K | 575K | 161K | 145K | 132K | 69K |
| Deferred Taxes | -1.64M | 358K | -820K | 1.34M | 362K | 90K | -178K | 17K | 102K | 104K |
| Other Non-Cash Items | -258K | 4.84M | 3.52M | 1.53M | 390K | 597K | 1.11M | 646K | -377K | 911K |
| Working Capital Changes | 4.36M | -2.11M | -16.12M | -2.24M | -1.89M | -6.63M | -6.1M | -4.88M | -5.08M | -6.13M |
| Change in Receivables | 2.71M | -375K | 0 | -3.4M | -6.01M | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 2.84M | -3.88M | 5.82M | 2.7M | -1.55M | 680K | 228K | 1M | 1.27M | 852K |
| Change in Payables | -392K | -116K | -953K | -102K | 182K | 52K | 181K | -94K | -341K | 305K |
| Cash from Investing | -278K | -214K | -189K | -211K | -225K | -143K | -46K | -30.07M | 8.15M | 8.12M |
| Capital Expenditures | -278K | -214K | -189K | -211K | -225K | -143K | -46K | -57K | -68K | -167K |
| CapEx % of Revenue | 0.14% | 0.11% | 0.24% | 0.34% | 0.38% | 0.29% | 0.1% | 0.13% | 0.17% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -17.22M | -31.51M | -17.46M | -9.14M | -9.14M | -9.14M | -9.21M | -9.21M | -9.21M | -14.78M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.14M |
| Equity Issued (Net) | 0 | 0 | -10.12M | 0 | 0 | 0 | 0 | 0 | 0 | -5.87M |
| Dividends Paid | -17.22M | -31.51M | -7.34M | -9.14M | -9.14M | -9.14M | -9.21M | -9.21M | -9.21M | -7.76M |
| Share Repurchases | 0 | 0 | -10.12M | 0 | 0 | 0 | 0 | 0 | 0 | -5.87M |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 9.39M▲ 0% | -2.83M▼ 130.1% | -36.23M▼ 1181.4% | -6.53M▲ 82.0% | -8.53M▼ 30.5% | -14.62M▼ 71.4% | -13.53M▲ 7.5% | -42.65M▼ 215.2% | -6.75M▲ 84.2% | -12.47M▲ 0% |
| Free Cash Flow | 26.33M▲ 0% | 29.5M▲ 12.0% | -18.83M▼ 163.8% | 1.67M▲ 108.9% | 791K▼ 52.7% | -5M▼ 731.5% | -4.32M▲ 13.4% | -3.42M▲ 20.8% | -6.07M▼ 77.1% | -6.3M▲ 0% |
| FCF Margin % | 13.33% | 15.37% | -24.26% | 2.7% | 1.32% | -10.17% | -9.84% | -7.97% | -15.25% | -16.48% |
| FCF Growth % | -49.63% | 12.04% | -163.83% | 108.89% | -52.75% | -731.48% | 13.43% | 20.81% | -77.13% | -80.4% |
| FCF per Share | 2.34 | 2.61 | -1.73 | 0.15 | 0.07 | -0.44 | -0.38 | -0.30 | -0.53 | -0.53 |
| FCF Conversion (FCF/Net Income) | 1.13x | 0.96x | 3.32x | 2.24x | 0.94x | -15.50x | -7.53x | -5.89x | 6.80x | 5.44x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 6.77M | 3.13M | 1.99M | 0 | 1.86M | 1.66M | 3.53M | 3.96M | 0 | 0 |
NHTC Key Ratios
Natural Health Trends Corp. (NHTC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 27.25% | 34.39% | -6.8% | 1.18% | 1.71% | 0.57% | 1.24% | 1.54% | -3.13% | -4.88% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | - | -17.93% | -6.5% | -6.5% |
| Gross Margin | 80.44% | 79.49% | 74.1% | 72.63% | 74.99% | 74.23% | 74.56% | 73.98% | 73.54% | 73.84% |
| Net Margin | 11.93% | 16.17% | -7.23% | 1.36% | 1.81% | 0.64% | 1.29% | 1.33% | -2.22% | -3.03% |
| Debt / Equity | - | - | 0.04x | 0.06x | 0.05x | 0.08x | 0.08x | 0.08x | 0.13x | 0.13x |
| FCF Conversion | 1.13x | 0.96x | 3.32x | 2.24x | 0.94x | -15.50x | -7.53x | -5.89x | 6.80x | 5.44x |
| Revenue Growth | -31.34% | -2.86% | -59.56% | -20.03% | -3.33% | -18.12% | -10.6% | -2.19% | -7.42% | -10.54% |
NHTC SEC Filings & Documents
Natural Health Trends Corp. (NHTC) SEC filings — annual & quarterly reports (10-K, 10-Q)
NHTC Frequently Asked Questions
Natural Health Trends Corp. (NHTC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Natural Health Trends Corp. (NHTC) reported $38.2M in revenue for fiscal year 2025. This represents a 430% increase from $7.2M in 1996.
Natural Health Trends Corp. (NHTC) saw revenue decline by 7.4% over the past year.
Natural Health Trends Corp. (NHTC) reported a net loss of $1.2M for fiscal year 2025.
Dividend & Returns
Yes, Natural Health Trends Corp. (NHTC) pays a dividend with a yield of 25.84%. This makes it attractive for income-focused investors.
Natural Health Trends Corp. (NHTC) has a return on equity (ROE) of -3.1%. Negative ROE indicates the company is unprofitable.
Natural Health Trends Corp. (NHTC) had negative free cash flow of $6.3M in fiscal year 2025, likely due to heavy capital investments.
Explore More NHTC
Natural Health Trends Corp. (NHTC) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates